Tech Company Financing Transactions
Genapsys Funding Round
Genapsys, based in Redwood City, received $37 million in investment from Decheng Capital, private investors and IPV Capital.
Transaction Overview
Company Name
Announced On
11/14/2013
Transaction Type
Venture Equity
Amount
$37,000,000
Round
Series B
Investors
Proceeds Purpose
With this financing and the strong backing of our investors, we now have all the pieces in place to deliver on the commercial promise of the GENIUS System and realize a 100x improvement in cost and efficacy as compared to existing technologies on the market.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Cardinal Way 3rd Floor
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
The GenapSys Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology provides a low cost, easy-to-use, fast, and accurate genome sequencing solution. We've enabled an unparalleled run cost and a simplified workflow with the first ever purely electronic sequencing chip, the key component in our fully integrated platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Myers
Chief Financial Officer
Britton Russell
Chief Operating Officer
Mary Stewart
Vice President
Larry Greenfield
VP - Engineering
Kosar Parizi
VP - Engineering
Hamid Rategh
VP - General Counsel
Dana Moss
VP - Human Resources
Radhika Warrier
VP - Product Management
Surekha Karudapuram
Browse more venture capital transactions:
Prev: 11/14/2013: PayByGroup venture capital transaction
Next: 11/14/2013: Catabasis Pharmaceuticals venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs